EUVIMEDEUVIMED entdecken
Crossref

Serum level of IFN-λ is elevated in idiopathic inflammatory myopathies

Jingping Wen, Mianjing Zhou, Yimei Lai, Lili Zhuang, Jia Shi, Zhangmei Lin, Binfeng Chen, Mengyuan Li, Niansheng Yang, Shuyi Wang

Clinical Rheumatology · 2025

DOI: 10.1007/s10067-024-07227-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Rheumatology, 2025. Verfasst von Jingping Wen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Clinical Immunology, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, China. Hauptthemen laut MEDLINE: Myositis, Interferons, Dermatomyositis, Interleukins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Idiopathic inflammatory myopathies (IIM) are a heterogeneous group of autoimmune disorders with uncertain pathogenesis. Interferon (IFN)-λ has recently been described as an important mediator of immune responses. The main purpose of this study is to find out whether IFN-λ is involved in IIM. METHODS: The published RNA-seq data of dermatomyositis (DM) muscle and IIM double negative (DN) B cells were analyzed. Serum IFN-λ1, IFN-λ2, and IFN-λ3 levels of 59 IIM patients and 29 healthy persons were determined by enzyme-linked immunosorbent assay (ELISA). The proportion of DN B cells and subsets as well as phosphorylated STAT1 (p-STAT1) levels in peripheral B cells was measured by flow cytometry. Ex vivo induction of double negative 2 (DN2) B cells were performed for validation. RESULTS: Type III IFN signaling pathway was enriched in muscle tissue from DM patients. Serum IFN-λ1, IFN-λ2, and IFN-λ3 levels were significantly higher in the IIM patients, especially patients with interstitial lung disease (ILD) and skin manifestations. Moreover, serum IFN-λ1 level was positively correlated with the disease activity. In addition, IIM patients with positive anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibodies exhibited higher serum IFN-λ1, IFN-λ2, and IFN-λ3 levels. The frequency of DN2 B cells were elevated in IIM patients' blood. Interestingly, the type III IFN signaling pathway was enriched in circulating DN2 B cells from IIM patients, which could induce T-bet+CD19hi DN2 B cell differentiation ex vivo. CONCLUSION: IFN-λ may participate in the pathogenesis of IIM by acting on DN2 B cells and serve as a disease biomarker for IIM patients. Key Points • Type III IFN signaling pathway is enriched in the involved muscles of DM patients. • Serum IFN-λ in IIM patients is correlated with disease activity and is higher in patients with ILD, skin lesions, and positive anti-MDA5 antibodies. • DN2 B cells with enriched type III IFN signaling pathway are accumulated in the peripheral blood of IIM patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MyositisInterferonsDermatomyositisInterleukinsHumansFemaleMaleMiddle AgedB-LymphocytesAdultSignal TransductionSTAT1 Transcription FactorAgedCase-Control StudiesInterferon Lambda

Stichwörter der Autor:innen

Double negative B lymphocytesIFN-λIdiopathic inflammatory myopathies

Substanzen

InterferonsSTAT1 Transcription Factorinterferon-lambda, humanInterleukinsInterferon Lambda

Autor:innen und Institutionen

  • Department of Rheumatology and Clinical Immunology, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, China.
  • Department of Rheumatology and Clinical Immunology, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, China. yangnsh@mail.sysu.edu.cn.
  • Department of Rheumatology and Clinical Immunology, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, China. wangshy259@mail.sysu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wen, J., Zhou, M., Lai, Y., Zhuang, L., Shi, J., Lin, Z., Chen, B., Li, M., Yang, N., & Wang, S. (2025). Serum level of IFN-λ is elevated in idiopathic inflammatory myopathies. Clinical Rheumatology. https://doi.org/10.1007/s10067-024-07227-5

Vancouver

Wen J, Zhou M, Lai Y, Zhuang L, Shi J, Lin Z, et al. Serum level of IFN-λ is elevated in idiopathic inflammatory myopathies. Clinical Rheumatology. 2025. doi:10.1007/s10067-024-07227-5

BibTeX
@article{Wen2025,
  author = {Wen, Jingping and Zhou, Mianjing and Lai, Yimei and Zhuang, Lili and Shi, Jia and Lin, Zhangmei and Chen, Binfeng and Li, Mengyuan and Yang, Niansheng and Wang, Shuyi},
  title = {Serum level of IFN-λ is elevated in idiopathic inflammatory myopathies},
  journal = {Clinical Rheumatology},
  year = {2025},
  doi = {10.1007/s10067-024-07227-5}
}
Kostenlos starten →